Improving melanoma classification by integrating genetic and morphologic features.

Area of Science:

• Oncology
• Dermatology
• Genetics

Background:

• Melanoma classification traditionally relies on morphology, but lacks predictive power for metastatic disease treatment.
• Genetic alterations, particularly BRAF and NRAS mutations, are key drivers of melanoma and therapeutic targets.
• Identifying morphological surrogates for genetic alterations can improve patient stratification and clinical trial analysis.

Purpose of the Study:

• To define and assess histomorphologic measures for predicting BRAF and NRAS mutations in primary cutaneous melanomas.
• To evaluate the clinical utility of morphological features and age as surrogates for BRAF mutation status.
• To correlate BRAF mutation status with patient survival and metastatic patterns.

Main Methods:

• A panel of histomorphologic measures was assessed in 302 archival primary cutaneous melanoma tissues.
• Morphological features were correlated with BRAF and NRAS oncogene mutation status.
• Age (<55 years) was evaluated as a surrogate for BRAF mutation in an independent cohort of 4,785 patients.

Main Results:

• Melanomas with BRAF mutations exhibited distinct features: increased intraepidermal melanocyte migration, epidermal thickening, sharper demarcation, and larger, rounder, pigmented tumor cells (p<0.0001).
• BRAF mutation status was predictable with up to 90.8% accuracy using morphological features and age <55.
• Age <55 was the most predictive factor for BRAF mutation, associated with improved survival and a distinct pattern of lymph node metastasis.

Conclusions:

• Refined morphological classification of primary melanomas can create genetically homogeneous subgroups.
• These subgroups are likely to exhibit differences in clinical outcomes and metastatic patterns.
• This approach can enhance melanoma classification, facilitate therapy stratification, and aid retrospective analysis of clinical trial data.